HOME >> BIOLOGY >> NEWS
Einstein's Susan Band Horwitz, PhD wins Bristol-Myers Squibb Cancer Research Award

BRONX, N.Y. Susan Band Horwitz, Ph.D., the Falkenstein Professor of Cancer Research and co-chair of the Department of Molecular Pharmacology at the Albert Einstein College of Medicine of Yeshiva University in New York, has been selected to receive the 29th annual Bristol-Myers Squibb Freedom to Discover Award for Distinguished Achievement in Cancer Research. She was recognized for her pioneering work over many decades in developing an understanding of the mechanisms of action of anti-tumor agents, especially complex natural products, as well as the mechanisms at the molecular level that cause resistance to these compounds. Her pivotal research in the 1980's eventually led to the development of paclitaxel (Taxol), one of the most important anti-cancer agents ever developed.

Dr. Horwitz was selected to receive the Distinguished Achievement Award by an independent panel of her peers, in a process in which Bristol-Myers Squibb takes no active role. The Award is a $50,000 cash prize and a silver commemorative medallion. Eighteen previous grant and award winners have also won Nobel Prizes.

While paclitaxel, found in the bark of the Pacific yew tree, was first identified in the early 1970's as a compound with a unique chemical structure and anti-tumor activity, it was not until Dr. Horwitz and her colleagues identified its singular mechanism of action for slowing tumor growth that the National Cancer Institute decided to undertake clinical trials, leading to its development and approval to treat a wide range of tumor types. Dr. Horwitz discovered that paclitaxel works by binding to microtubules, structures found in all cells and important in a wide range of cellular functions, including cell division. By stabilizing microtubules and thereby interfering with the normal functions of microtubules, paclitaxel in effect can halt or impede uncontrolled cancer cell growth. Today, paclitaxel remains widely used in the treatment of many types of pervasive tu
'"/>

Contact: Karen Gardner
kgardner@aecom.yu.edu
718-430-3101
Albert Einstein College of Medicine
26-Apr-2006


Page: 1 2 3

Related biology news :

1. Einsteins Dr. Vern Schramm elected to the National Academy of Sciences
2. Einsteins Dr. E. Richard Stanley receives 2006 E. Donnall Thomas Prize
3. Past AACR president Susan B. Horwitz elected to National Academy of Sciences
4. HSPHs Walter Willett wins Bristol-Myers Squibb/Mead Johnson Freedom to Discover Award
5. Journalists can register now for ECCO 14 -- the European Cancer Conference
6. Cancer cures could work for canines and humans
7. The Cancer Genome Atlas awards funds for technology development
8. Cancer research specialist and HSPH professor awarded Medal of Honor from WHO cancer agency
9. Cancer stem cells similar to normal stem cells can thwart anti-cancer agents
10. Cancer stem cells can go it alone
11. Cancer drug enhances long-term memory

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: